A carregar...

Cancer Immunotherapy: Sipuleucel-T and Beyond

In April 2010, sipuleucel-T became the first anticancer vaccine approved by the United States Food and Drug Administration. Different from the traditional chemotherapy agents that produce widespread cytotoxicity to kill tumor cells, anticancer vaccines and immunotherapies focus on empowering the imm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hammerstrom, Aimee E., Cauley, Diana H., Atkinson, Bradley J., Sharma, Padmanee
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4159742/
https://ncbi.nlm.nih.gov/pubmed/21923608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1592/phco.31.8.813
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!